Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Aims Epigenetic regulators, including microRNAs(miRNAs), are implicated in type 2 diabetes, but evidence linking circulating miRNAs in pregnancy and risk of gestational diabetes(GDM) is sparse. Potential modifiers, including pre-pregnancy overweight/obesity and offspring sex, are unexamined. We hypothesized that circulating levels of early-mid-pregnancy(range 7-23 weeks of gestation) candidate miRNAs are related to subsequent development of GDM. We also hypothesized that miRNA-GDM associations might vary by pre-pregnancy body-mass index(ppBMI) or offspring sex. Methods In a case-control analysis(36 GDM cases/80 controls) from the Omega study, a prospective cohort study of pregnancy complications, we measured early–mid-pregnancy plasma levels of 10 miRNAs chosen for potential roles in pregnancy course and complications(miR-126-3p, -155-5p, -21-3p, -146b-5p, -210-3p, -222-3p, -223-3p, -517-5p, -518a-3p, and 29a-3p) using qRT-PCR. Logistic regression models adjusted for gestational age at blood draw (GA) were fit to compare circulating miRNAs between cases and controls. We repeated analyses among overweight/obese(ppBMI≥25kg/m2) or lean(ppBMI<25kg/m2) women, and women with male or female offspring separately. Results Mean age was 34.3 years(cases) and 32.9 years(controls). GA-adjusted miR-155-5p(β=0.260/p=0.028) and - 21-3p(β=0.316/p=0.005) levels were positively associated with GDM. MiR-146b-5p(β=0.266/p=0.068) and miR-517-5p(β=0.196/p=0.074) were borderline. Associations of miR-21-3p and miR-210-3p with GDM were observed among overweight/obese but not lean women. Associations of six miRNAs(miR-155-5p, -21-3p, - 146b-5p, -223-3p, -517-5p, and -29a-3p) with GDM were present only among women carrying male fetuses(all p<0.05). Conclusions Circulating early–mid-pregnancy miRNAs are associated with GDM, particularly among women who are overweight/obese pre-pregnancy or pregnant with male offspring. This area has potential to clarify mechanisms underlying GDM pathogenesis and identify at-risk mothers earlier in pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Policy: NIH to balance sex in cell and animal studies
Clayton, J. A., & Collins, F. S. (2014) · Nature · doi:10.1038/509282a · Cited by 1,816
Gene expression patterns in human placenta
Sood, R., Zehnder, J. L., Druzin, M. L., & Brown, P. O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508035103 · Cited by 454
Feig, D. S., Hwee, J., Shah, B. R., Booth, G. L., Bierman, A. S., & Lipscombe, L. L. (2014) · Diabetes Care · doi:10.2337/dc13-2717 · Cited by 346 · cited 1×
“Gestational diabetes (GDM) is increasingly common, affecting 5-15% of pregnancies[1], and is implicated in”
BackgroundEarly Second-Trimester Serum MiRNA Profiling Predicts Gestational Diabetes Mellitus
Zhao, C., Dong, J., Jiang, T., Shi, Z., Yu, B., Zhu, Y., Chen, D., Xu, J., Huo, R., Dai, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023925 · Cited by 230 · cited 5×
“performed a pilot study using high-throughput sequencing on pooled plasma samples (collected at 16-19 weeks gestational age) from 10 GDM cases (based on 75-g OGTT results) and 10 age- and gestational-age–matched controls, followed by qRT-PCR confirmatory experiments[34, 35].”
BackgroundMethodInfluentialFetal Sex and Maternal Risk of Gestational Diabetes Mellitus: The Impact of Having a Boy
Retnakaran, R., Kramer, C. K., Ye, C., Kew, S., Hanley, A. J., Connelly, P. W., Sermer, M., & Zinman, B. (2015) · Diabetes Care · doi:10.2337/dc14-2551 · Cited by 166
A Critical Evaluation of microRNA Biomarkers in Non-Neoplastic Disease
Haider, B. A., Baras, A. S., McCall, M. N., Hertel, J. A., Cornish, T. C., & Halushka, M. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089565 · Cited by 157
Cindrova-Davies, T., Herrera, E. A., Niu, Y., Kingdom, J., Giussani, D. A., & Burton, G. J. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.001 · Cited by 135
A MicroRNA Signature in Gestational Diabetes Mellitus Associated with Risk of Macrosomia
Li, J., Song, L., Zhou, L., Wu, J., Sheng, C., Chen, H., Liu, Y., Gao, S., & Huang, W. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430349 · Cited by 123 · cited 7×
“including miRNAs, may also have important roles in GDM, a condition that shares similar pathophysiologic features to T2D[28-33].”
BackgroundInfluentialAge- and glycemia-related miR-126-3p levels in plasma and endothelial cells
Olivieri, F., Bonafè, M., Spazzafumo, L., Gobbi, M., Prattichizzo, F., Recchioni, R., Marcheselli, F., Sala, L. L., Galeazzi, R., Rippo, M. R., et al. (2014) · Aging · doi:10.18632/aging.100693 · Cited by 118 · cited 1×
“, miR-126, -146a, and -29a) comparing type 2 diabetes (T2D) cases to controls[13, 18-27].”
Background
Cited by
Lorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., & Lorenzo, Ó. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0935-9 · Cited by 202
Molecular Biomarkers for Gestational Diabetes Mellitus and Postpartum Diabetes
Lu, W., & Hu, C. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002160 · Cited by 52
“miRNAs have been associated with GDM and its health complications and may have diagnostic, prognostic, and predictive value.([27-29]) Three common methods for miRNA analysis are miRNA sequencing, microarray, and quantitative real-time PCR (qRT-PCR).”
MethodBiochemical and Molecular Biomarkers: Unraveling Their Role in Gestational Diabetes Mellitus
Karami, M., Mousavi, S. H., Rafiee, M., Heidari, R., & Shahrokhi, S. Z. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00980-8 · Cited by 33
Exploring the potential of microRNA as a diagnostic tool for gestational diabetes
Elhag, D. A., & Al Khodor, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04269-2 · Cited by 20
“Interestingly, miR-29a was found to have a significantly higher level in plasma of Canadian women with GDM, but two previous studies on Chinese women with GDM showed a significantly downregulated pattern of miR-29a and miR-29b in serum and placental samples, respectively [35, 36, 97, 98].”
BackgroundResultInfluential
Metadata
- Authors
- Wander, P. L., Boyko, E. J., Hevner, K., Parikh, V. J., Tadesse, M. G., Sorensen, T. K., Williams, M. A., & Enquobahrie, D. A.
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 132
- Pages
- 1-9
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2736819442
- Cited by
- 111
- References
- 11
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.